Butaphosphan is indicated for use in veterinary medicine as a metabolic support and to improve energy balance in animals during periods of high energy demand, such as in the following situations:

• Treatment of metabolic disorders (e.g., ketosis) in cattle and other farm animals.
• Support during convalescence in debilitated or sick animals.
• Support during intense exercise or high-performance activities in sport animals.

• The dosage and administration of Butaphosphan may vary depending on the species, weight, and condition of the animal, as well as the veterinarian's assessment. It is typically administered by intramuscular or subcutaneous injection.
• It is important to follow the recommended dosages and treatment schedules provided by the veterinarian.

Adverse reactions to Butaphosphan are rare but may include:

• Local injection site reactions (e.g., swelling, pain, or redness at the injection site).
• Allergic reactions (e.g., rash, itching, or hives) in sensitive animals.

• Butaphosphan should only be administered by a qualified veterinarian.
• Avoid injecting the drug intravenously, as it may cause adverse effects and be harmful to the animal.
• Use with caution in animals with pre-existing renal or hepatic impairment, as Butaphosphan is primarily eliminated by the kidneys and liver.
• Use in pregnant or lactating animals should be done with caution, and the potential benefits and risks should be evaluated by the veterinarian.